Display Settings:

Format

Send to:

Choose Destination
Nature. 1996 Aug 22;382(6593):685-91.

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

Author information

  • 1Department of Pathology, Columbia University, College of Physicians and Surgeons, New York 10032, USA.

Abstract

Amyloid-beta peptide is central to the pathology of Alzheimer's disease, because it is neurotoxic--directly by inducing oxidant stress, and indirectly by activating microglia. A specific cell-surface acceptor site that could focus its effects on target cells has been postulated but not identified. Here we present evidence that the 'receptor for advanced glycation end products' (RAGE) is such a receptor, and that it mediates effects of the peptide on neurons and microglia. Increased expressing of RAGE in Alzheimer's disease brain indicates that it is relevant to the pathogenesis of neuronal dysfunction and death.

Comment in

PMID:
8751438
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk